Dosing is individualized, but a typical protocol titrates from a starting dose up to a target dose over 2 to 4 weeks, injected 5 days on and 2 days off, in defined cycles with scheduled breaks between them
Orexin-A is a neuropeptide that was abnormally decreased or undetectable in the CSF of a large proportion of patients with narcolepsy
Patients receive medications via shipping without an in-person evaluation, InBody scan, or face-to-face provider review
No.:GL-VL-0109 CAS CAS:N/A Formula:Lyophilized MW:Variable (polymeric) Batch No.:QC2026-VL0109-8234 Mfg Date:2026-02-18 Test Date:2026-02-22 Sample Wt.:33.1 mg Appearance:White lyophilized powder in sealed vials Storage:2-8C, protect from light Spec.: Q/SH-VL-2026 Analytical Method & Instrumentation Method:Reversed-Phase HPLC (USP , ChP 0512) Instrument:Agilent 1260 Infinity II HPLC System (SN: DE39810) Column:Agilent ZORBAX Eclipse Plus C18, 2504.6mm, 5m (Lot: B32997) A Mobile Phase A:0.1% Trifluoroacetic acid (TFA) in Milli-Q Water (18.2 Mcm) B Mobile Phase B:0.1% TFA in Acetonitrile (HPLC Grade, Fisher Scientific) Gradient:0min5%B, 5min20%B, 20min60%B, 28min95%B, 30min95%B / Flow/Temp:1.0 mL/min / 30.0 0.5C (thermostatted) Detection:UV-DAD at 220nm (bandwidth 4nm, ref 360nm) Injection:20 L, sample conc
How are products shipped temperature-sensitive
